Robert E. Hurst

5.7k total citations
153 papers, 4.2k citations indexed

About

Robert E. Hurst is a scholar working on Molecular Biology, Cell Biology and Surgery. According to data from OpenAlex, Robert E. Hurst has authored 153 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 44 papers in Cell Biology and 39 papers in Surgery. Recurrent topics in Robert E. Hurst's work include Proteoglycans and glycosaminoglycans research (38 papers), Urinary Bladder and Prostate Research (27 papers) and Bladder and Urothelial Cancer Treatments (26 papers). Robert E. Hurst is often cited by papers focused on Proteoglycans and glycosaminoglycans research (38 papers), Urinary Bladder and Prostate Research (27 papers) and Bladder and Urothelial Cancer Treatments (26 papers). Robert E. Hurst collaborates with scholars based in United States, Canada and China. Robert E. Hurst's co-authors include George P. Hemstreet, Rebecca B. Bonner, Daniel J. Culkin, Kimberly D. Kyker, C. Lowell Parsons, Paul Hauser, Hugh J. Callahan, Lowell Parsons, Susan Jones and Mikhail G. Dozmorov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Robert E. Hurst

152 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Hurst United States 37 1.5k 1.2k 919 703 657 153 4.2k
Pavel Strnad Germany 40 349 0.2× 1.8k 1.4× 794 0.9× 1.7k 2.5× 1.6k 2.5× 161 5.7k
Zhou Wang China 35 289 0.2× 2.0k 1.6× 333 0.4× 247 0.4× 179 0.3× 242 4.3k
Heng Lin Taiwan 43 172 0.1× 2.9k 2.4× 333 0.4× 463 0.7× 1.1k 1.7× 135 5.4k
Normand Marceau Canada 37 246 0.2× 1.9k 1.6× 989 1.1× 1.5k 2.1× 319 0.5× 106 4.2k
Shigetoshi Sano Japan 42 184 0.1× 2.0k 1.6× 208 0.2× 490 0.7× 366 0.6× 169 6.4k
Yoichi Yamada Japan 30 156 0.1× 2.0k 1.7× 371 0.4× 906 1.3× 137 0.2× 115 3.7k
Rocío Ortiz‐López Mexico 27 150 0.1× 1.8k 1.5× 316 0.3× 171 0.2× 385 0.6× 156 3.8k
Roberto Benelli Italy 45 142 0.1× 2.6k 2.1× 467 0.5× 277 0.4× 443 0.7× 123 6.7k
Junfeng Zhang China 47 171 0.1× 3.2k 2.6× 591 0.6× 157 0.2× 394 0.6× 119 6.5k
Taro Hayakawa Japan 42 136 0.1× 1.8k 1.5× 482 0.5× 531 0.8× 260 0.4× 140 5.7k

Countries citing papers authored by Robert E. Hurst

Since Specialization
Citations

This map shows the geographic impact of Robert E. Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Hurst more than expected).

Fields of papers citing papers by Robert E. Hurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Hurst. The network helps show where Robert E. Hurst may publish in the future.

Co-authorship network of co-authors of Robert E. Hurst

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Hurst. A scholar is included among the top collaborators of Robert E. Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Hurst. Robert E. Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thapa, Pritam, et al.. (2021). Singlet Oxygen Activatable Prodrugs of Paclitaxel, SN‐38, MMC and CA4: Nonmitochondria‐Targeted Prodrugs†. Photochemistry and Photobiology. 98(2). 389–399. 6 indexed citations
2.
Sauer, Scott J., Damon R. Reed, Michael A. Ihnat, et al.. (2021). Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells. Frontiers in Oncology. 11. 659963–659963. 45 indexed citations
3.
Bio, Moses, et al.. (2019). Singlet oxygen-activatable Paclitaxel prodrugs via intermolecular activation for combined PDT and chemotherapy. Bioorganic & Medicinal Chemistry Letters. 29(12). 1537–1540. 18 indexed citations
4.
Schütz, L.F., Robert E. Hurst, Nicole B. Schreiber, & L. J. Spicer. (2018). Transcriptome profiling of bovine ovarian theca cells treated with fibroblast growth factor 9. Domestic Animal Endocrinology. 63. 48–58. 9 indexed citations
5.
Davis, Carole, Paul Hauser, Robert E. Hurst, et al.. (2017). Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer. Nanotechnology. 29(3). 35101–35101. 43 indexed citations
6.
Bio, Moses, et al.. (2017). Efficient activation of a visible light-activatable CA4 prodrug through intermolecular photo-unclick chemistry in mitochondria. Chemical Communications. 53(11). 1884–1887. 22 indexed citations
7.
Hurst, Robert E., et al.. (2016). Sexually dimorphic effects of early life stress in rat pups on urinary bladder detrusor muscle contractility in adulthood. Biology of Sex Differences. 7(1). 8–8. 5 indexed citations
8.
Hurst, Robert E., Paul Hauser, Youngjae You, et al.. (2015). Identification of novel drugs to target dormant micrometastases. BMC Cancer. 15(1). 404–404. 11 indexed citations
9.
10.
Saban, Marcia R., Carole Davis, António Avelino, et al.. (2011). VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG. BMC Physiology. 11(1). 16–16. 24 indexed citations
11.
Saban, Ricardo, Michael R. D’Andrea, Patricia Andrade‐Gordon, et al.. (2007). Regulatory network of inflammation downstream of proteinase-activated receptors. BMC Physiology. 7(1). 3–3. 30 indexed citations
12.
Hurst, Robert E., Chandrashekhar D. Kamat, Kimberly D. Kyker, Dixy E. Green, & Michael A. Ihnat. (2004). A novel multidrug resistance phenotype of bladder tumor cells grown on Matrigel or SIS gel. Cancer Letters. 217(2). 171–180. 12 indexed citations
13.
Saban, Marcia R., et al.. (2003). Gene expression profiling of inflammatory bladder disorders. Expert Review of Molecular Diagnostics. 3(2). 217–235. 8 indexed citations
14.
Waliszewski, Przemysław, et al.. (1999). Retinoid signaling in immortalized and carcinoma-derived human uroepithelial cells. Molecular and Cellular Endocrinology. 148(1-2). 55–65. 9 indexed citations
15.
Hurst, Robert E., Rebecca B. Bonner, K. Ashenayi, Robert W. Veltri, & George P. Hemstreet. (1997). Neural net‐based identification of cells expressing the p300 tumor‐related antigen using fluorescence image analysis. Cytometry. 27(1). 36–42. 2 indexed citations
16.
Hurst, Robert E., Rebecca B. Bonner, K. Ashenayi, Robert W. Veltri, & George P. Hemstreet. (1997). Neural net-based identification of cells expressing the p300 tumor-related antigen using fluorescence image analysis. Cytometry. 27(1). 36–42. 16 indexed citations
17.
Hurst, Robert E., Johnny B. Roy, Kyung‐Whan Min, et al.. (1996). A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology. 48(5). 817–821. 103 indexed citations
18.
Hurst, Robert E., et al.. (1988). The identification of a heparin-binding protein on the surface of bovine sperm. Biochemical and Biophysical Research Communications. 153(1). 289–293. 15 indexed citations
19.
Hennessey, Patrick T., Robert E. Hurst, George P. Hemstreet, & Gary Cutter. (1981). Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma.. PubMed. 41(10). 3868–73. 43 indexed citations
20.
Hurst, Robert E., et al.. (1972). Evaluation of the Maturity of Fetal Lungs: A Simplified, Inexpensive Modification of Amniotic Fluid Analysis by Thin-layer Chromatography. American Journal of Clinical Pathology. 58(5). 579–582. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pavel Strnad Breakdown of academic impact, for papers by Zhou Wang Breakdown of academic impact, for papers by Heng Lin Breakdown of academic impact, for papers by Normand Marceau Breakdown of academic impact, for papers by Shigetoshi Sano Breakdown of academic impact, for papers by Yoichi Yamada Breakdown of academic impact, for papers by Rocío Ortiz‐López Breakdown of academic impact, for papers by Roberto Benelli Breakdown of academic impact, for papers by Junfeng Zhang Breakdown of academic impact, for papers by Taro Hayakawa
Rankless by CCL
2026